Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis
Posted by Leanne Kodsman on
Pooled Normal Human Serum from Innovative Research was recently used in the following study:
Journal of Molecular Medicine, September 2018
Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis
Yan Li, Fiona Clow, John D. Fraser, Feng LinJournal of Molecular Medicine, September 2018
" ... Recombinant SSL7 and SSL7-C5a SSL7 mutant lacking C5 binding activity were overexpressed in Escherichia coli and purified following the protocol described in previous reports [16, 20]. Pooled normal human serum (NHS) as the source of complement was purchased from Innovative Research (Novi, MI)."
Related products available from Innovative Research also include:
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Monoclonal Antibody to VLDLR (MA-1H10): An Explainer
The Innovative Research lab pulled together an explainer on one of our recently popular...
Read the ArticleUpdate Post: A Timeline of Hemophilia Research
Hemophilia is a bleeding disorder in which the body is unable to form blood clots prope...
Read the ArticleUpdated Blog Post: The Importance of Human Serum
Human blood is composed of several important components, each serving different functio...
Read the Article